Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • Global United States
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow down
      < Back
    • Science
    • Areas of focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
  1. Home
  2. Who We Are
  3. Leadership
  4. Emad Abdelnaby

Emad Abdelnaby

Back
Emad Abdelnaby

Emad Abdelnaby

  • Senior Vice President,
  • Franchise Head, Oncology Business Unit
  • Follow in LinkedIn

Emad joined Ipsen in January of 2024 as Senior Vice President and Franchise Head of Oncology, bringing 25 years of extensive healthcare experience across multiple therapeutic areas.

In this role, Emad will support and accelerate the growth of Ipsen’s Oncology Franchise in the U.S. market.

Prior to joining Ipsen, Emad led Johnson & Johnson’s Solid Tumor business in Japan. In addition to his breadth of experience across therapeutic areas and businesses, Emad has also held roles of increasing responsibility for pharmaceutical organizations around the globe including Pfizer, Novartis, Merck KGaA and Johnson & Johnson.

Emad is a graduate of Yale University where he received his B.A. in History and Political Science with a focus on International Relations. He received his M.B.A. in Management from the Stern School of Business at New York University and also holds a Master of Health Care Innovation from the University of Pennsylvania Perelman School of Medicine.

IPN price

€103.70

 €1.40 (1.37%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2025

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue